dc.contributor.author | Kaudewitz, D | en_US |
dc.contributor.author | Skroblin, P | en_US |
dc.contributor.author | Bender, LH | en_US |
dc.contributor.author | Barwari, T | en_US |
dc.contributor.author | Willeit, P | en_US |
dc.contributor.author | Pechlaner, R | en_US |
dc.contributor.author | Sunderland, NP | en_US |
dc.contributor.author | Willeit, K | en_US |
dc.contributor.author | Morton, AC | en_US |
dc.contributor.author | Armstrong, PC | en_US |
dc.contributor.author | Chan, MV | en_US |
dc.contributor.author | Lu, R | en_US |
dc.contributor.author | Yin, X | en_US |
dc.contributor.author | Gracio, F | en_US |
dc.contributor.author | Dudek, K | en_US |
dc.contributor.author | Langley, SR | en_US |
dc.contributor.author | Zampetaki, A | en_US |
dc.contributor.author | de Rinaldis, E | en_US |
dc.contributor.author | Ye, S | en_US |
dc.contributor.author | Warner, TD | en_US |
dc.contributor.author | Saxena, A | en_US |
dc.contributor.author | Kiechl, S | en_US |
dc.contributor.author | Storey, RF | en_US |
dc.contributor.author | Mayr, M | en_US |
dc.date.accessioned | 2017-05-16T13:51:13Z | |
dc.date.available | 2015-12-08 | en_US |
dc.date.issued | 2016-02-05 | en_US |
dc.date.submitted | 2017-02-16T17:18:23.097Z | |
dc.identifier.issn | 0009-7330 | en_US |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/23128 | |
dc.description.sponsorship | This research was conducted with support from AstraZeneca UK Limited. This study was also supported by the National Institute for Health Research Biomedical Research Centre based at Guy’s and St Thomas’ National Health Service Foundation Trust and King’s College London in partnership with King’s College Hospital, the Fondation Leducq (MIRVAD), Diabetes UK, the Juvenile Diabetes Research Foundation, and by an excellence initiative (Competence Centers for Excellent Technologies) of the Austrian Research Promotion Agency FFG: Research Center of Excellence in Vascular Ageing—Tyrol, VASCage (K-Project no. 843536) funded by the BMVIT, BMWFW, the Wirtschaftsagentur Wien, and the Standortagentur Tirol. | en_US |
dc.format.extent | 420 - 432 | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | CIRCULATION RESEARCH | en_US |
dc.subject | biomarkers | en_US |
dc.subject | acute coronary syndrome | en_US |
dc.subject | blood platelet | en_US |
dc.subject | polymorphism, single nucleotide | en_US |
dc.subject | micro-RNAs | en_US |
dc.title | Association of MicroRNAs and YRNAs With Platelet Function | en_US |
dc.type | Article | |
dc.rights.holder | © 2015 American Heart Association, Inc. | |
dc.identifier.doi | 10.1161/CIRCRESAHA.114.305663 | en_US |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000371014400010&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.issue | 3 | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 118 | en_US |